We are live on ! Find out more
John Rogers

John Rogers Ariel Investments

AUM $10B Turnover 14.04%
1-Year Est. Return 42.59%
 

John W. Rogers Jr. is the founder of Ariel Investments, one of the best-known minority-owned investment firms in the United States. Ariel is associated with patient, value-oriented investing and a long-term “slow and steady” culture. Rogers is also a prominent voice on markets, corporate leadership, and inclusive capitalism.

This Fund
S&P 500
This Quarter Est. Return
+19.34%
1 Year Est. Return
+42.59%
3 Year Est. Return
+78.13%
5 Year Est. Return
+79.56%
10 Year Est. Return
+301.99%
AUM
$10B
AUM Growth
+$1.09B
Cap. Flow
-$215M
Cap. Flow %
-2.14%
Top 10 Hldgs %
33.02%
Holding
114
New
8
Increased
33
Reduced
63
Closed
8
Avg Time Held
5.8 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
3 years

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$132M
2
RLI icon
RLI Corp
RLI
+$88.4M
3
MAS icon
Masco
MAS
+$77.6M
4
PPL icon
PPL Corp
PPL
+$49.9M
5
HLI icon
Houlihan Lokey
HLI
+$36.1M

Top Sells

Rank Stock Value
1
SPHR icon
Sphere Entertainment
SPHR
+$111M
2
INTC icon
Intel
INTC
+$91.7M
3
AQN icon
Algonquin Power & Utilities
AQN
+$79.1M
4
GNRC icon
Generac Holdings
GNRC
+$74.3M
5
MSGE icon
Madison Square Garden
MSGE
+$54.8M

Sector Composition

Rank Sector Weight
1 Financials 19.3%
2 Consumer Discretionary 17.41%
3 Healthcare 15.53%
4 Communication Services 13.77%
5 Industrials 12.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
REZI icon
26
Resideo Technologies
REZI
$2.5B
$191M 1.9%
6,141,052
+62,201
+1% +$2.14M
2021 Q3
19 quarters
NTRS icon
27
Northern Trust
NTRS
$30.3B
$169M 1.69%
972,340
-168,778
-15% -$27.8M
2013 Q2
52 quarters
CLB icon
28
Core Laboratories
CLB
$459M
$164M 1.64%
14,074,945
+904,557
+7% +$12.9M
2020 Q2
24 quarters
HAE icon
29
Haemonetics
HAE
$5.38B
$155M 1.54%
+2,060,966
New +$132M
2026 Q2
0 quarters
RLI icon
30
RLI Corp
RLI
$5.6B
$149M 1.48%
2,519,527
+1,647,494
+189% +$88.4M
2025 Q4
2 quarters
MAS icon
31
Masco
MAS
$14.4B
$133M 1.33%
1,635,096
+1,111,667
+212% +$77.6M
2018 Q4
30 quarters
AXTA icon
32
Axalta
AXTA
$7.16B
$118M 1.18%
3,462,010
-4,950
-0.1% -$149K
2021 Q1
21 quarters
ADT icon
33
ADT
ADT
$5.02B
$116M 1.16%
17,858,375
-1,616,677
-8% -$11.1M
2021 Q2
20 quarters
LH icon
34
Labcorp
LH
$25.8B
$97.8M 0.97%
349,112
-4,907
-1% -$1.29M
2014 Q1
49 quarters
SMG icon
35
ScottsMiracle-Gro
SMG
$3.18B
$96.1M 0.96%
1,410,981
+448,339
+47% +$27.8M
2026 Q1
1 quarter
KN icon
36
Knowles
KN
$2.86B
$94.8M 0.94%
2,284,673
-1,534,189
-40% -$53.3M
2018 Q4
30 quarters
BCO icon
37
Brink's
BCO
$4.31B
$86.1M 0.86%
911,321
-11,637
-1% -$1.21M
2013 Q2
52 quarters
OMC icon
38
Omnicom Group
OMC
$22.1B
$85.5M 0.85%
1,174,452
+69,507
+6% +$5.23M
2025 Q4
2 quarters
XRAY icon
39
Dentsply Sirona
XRAY
$1.71B
$85.2M 0.85%
8,026,107
+1,639,292
+26% +$17.9M
2025 Q4
2 quarters
LIND icon
40
Lindblad Expeditions
LIND
$2.26B
$78M 0.78%
2,762,484
-676,579
-20% -$14.3M
2021 Q4
18 quarters
INTC icon
41
Intel
INTC
$475B
$76.6M 0.76%
548,831
-906,460
-62% -$91.7M
2023 Q4
10 quarters
CVS icon
42
CVS Health
CVS
$118B
$75.5M 0.75%
730,110
+27,959
+4% +$2.5M
2024 Q1
9 quarters
LFUS icon
43
Littelfuse
LFUS
$9.7B
$74.4M 0.74%
163,376
-52,051
-24% -$22.5M
2013 Q2
52 quarters
DIS icon
44
Walt Disney
DIS
$191B
$61.2M 0.61%
635,446
-18,923
-3% -$1.93M
2025 Q2
4 quarters
FSLR icon
45
First Solar
FSLR
$18.6B
$57.2M 0.57%
242,450
-29,030
-11% -$6.81M
2025 Q2
4 quarters
GCMG icon
46
GCM Grosvenor
GCMG
$768M
$54.3M 0.54%
4,415,839
+19,436
+0.4% +$213K
2022 Q3
15 quarters
SLB icon
47
SLB Ltd
SLB
$73.5B
$54.1M 0.54%
1,163,320
-74,079
-6% -$3.97M
2024 Q4
6 quarters
FDS icon
48
Factset
FDS
$10.7B
$53.9M 0.54%
234,096
+9,049
+4% +$2.08M
2025 Q4
2 quarters
KEYS icon
49
Keysight
KEYS
$56.4B
$51M 0.51%
145,711
-58,613
-29% -$20M
2016 Q4
38 quarters
NVT icon
50
nVent Electric
NVT
$23B
$50.7M 0.51%
299,032
-297,367
-50% -$46.4M
2021 Q1
21 quarters
1
2
3 4 5

Similar funds

OFI Invest Asset Management
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Allstate Corporation
Allstate Corporation Northbrook, Illinois $10B AUM 30.74% 1-Year Est. Return
NewEdge Wealth
NewEdge Wealth Pittsburgh, Pennsylvania $10B AUM 30.45% 1-Year Est. Return
LBP AM
LBP AM Paris, France $10B AUM 43.88% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Brookstone Capital Management
Brookstone Capital Management Wheaton, Illinois $10B AUM 23.61% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $10.1B AUM 10.46% 1-Year Est. Return
Stratos Wealth Partners
Stratos Wealth Partners Beachwood, Ohio $9.9B AUM 28.91% 1-Year Est. Return

John Rogers's Q2 2026 Portfolio in Review

As of Q2 2026, John Rogers held 114 positions worth $10B, up 12% from $8.93B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John Rogers's Q2 2026 filing shows 8 new, 33 increased, 63 reduced and 8 closed positions. Its largest new stake was Haemonetics: 2,060,966 shares worth $155M. The largest sale was Sphere Entertainment, an estimated $111M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • John Rogers's largest Q2 2026 buy was Haemonetics: 2,060,966 shares worth $155M.
  • John Rogers added most to RLI Corp in Q2 2026, an estimated $88.4M increase.
  • John Rogers's biggest Q2 2026 reduction was Sphere Entertainment, cutting an estimated $111M.
  • John Rogers fully exited Stanley Black & Decker in Q2 2026, selling an estimated $28.2M.
  • John Rogers's ten largest holdings make up 33% of its $10B portfolio in Q2 2026.
  • John Rogers opened 8 new positions and closed 8 in Q2 2026.
  • John Rogers's portfolio value rose 12% quarter-over-quarter to $10B.

Based on Ariel Investments's 13F filing for Q2 2026, filed 14 Aug 2026.